OPKO Health Inc (NAS:OPK)
$ 1.5 +0.035 (+2.41%) Market Cap: 1.13 Bil Enterprise Value: 1.19 Bil PE Ratio: 0 PB Ratio: 0.94 GF Score: 55/100

OPKO Health Inc at JPMorgan Healthcare Conference Transcript

Jan 14, 2026 / 09:30PM GMT
Release Date Price: $1.3 (-2.99%)
Brian Cheng
JPMorgan Chase & Co - Analyst

Good afternoon, and welcome back. Thanks for joining us for another session at the 44th JPMorgan Healthcare Conference. I'm Brian Cheng. I'm one of the senior biotech analysts here at the firm. On stage, we have the team from OPKO Health.

And here, the session here is a fireside session with the team. Maybe the OPKO team can introduce themselves, who do we have on this stage?

Elias Zerhouni
OPKO Health Inc - President, Vice Chairman of the Board

Sorry. Can you hear me okay?

Brian Cheng
JPMorgan Chase & Co - Analyst

Yes.

Elias Zerhouni
OPKO Health Inc - President, Vice Chairman of the Board

I'm Elias Zerhouni, I'm the President of OPKO Health. I became President of OPKO Health because I cofounded a company called ModeX Therapeutics, which was acquired by OPKO Health in 2022. As part of that, I ended up being President of the acquiring company. And I'm a former Head of R&D at Sanofi, I'm a former Head of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot